Prolyl hydroxylase domain-containing protein (PHD) inhibitors and uses thereof
US12209101B2 · kind B2 · utility
0Cited by
8References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 31, 2023 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | Aug 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6584
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are PHD inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of anemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.